Therapeutic concentrations of antiâ•'epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24â•
2 "Lotte Stapper" profiles | LinkedIn
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Francois Le Vu on LinkedIn: #McKGlobalB2B #omnichannel #B2BSales
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Developing blockbuster drugs: both nature and nurture
Self-learning: The dawn of a new biomedical R&D paradigm | McKinsey
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Tobias Silberzahn on LinkedIn: #digitalhealth #healthtech #futureofhealth
Lotte | McKinsey & Company
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
GRANDPRIX TV - LOTTE BERGHAUSER PONT
The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells | PLOS ONE
Self-learning: The dawn of a new biomedical R&D paradigm | McKinsey
RePub, Erasmus University Repository: ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Impact of COVID-19 on pharmaceutical external innovation sourcing
Tobias Silberzahn on LinkedIn: The Future of Patient Care Symposium 2022 – APACMed
